Sarah Martin
Australian National University(AU)The University of Queensland(AU)University of Kent(GB)AARNet (Australia)(AU)Act Health(AU)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Reproductive tract infections research, HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk
Most-Cited Works
- → RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain(2013)477 cited
- → Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study(2018)365 cited
- → Dual kinase-bromodomain inhibitors for rationally designed polypharmacology(2014)348 cited
- → Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains(2014)282 cited
- → Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy(2015)225 cited
- → Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance(2015)143 cited